Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
A nearly impenetrable stroma and hypovascularity limit drug delivery to pancreatic ductal adenocarcinoma (PDAC) cells and thus the effectiveness of treatments,...